Clinical trial

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE3

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2015-01-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Parkinson's Diseaseunresolved

Interventions

Levodopa-carbidopa intestinal gelDRUG

CADD-Legacy® 1400 ambulatory infusion pumpDEVICE

J-tubeDEVICE

Sponsors & collaborators

AbbVie (prior sponsor, Abbott)lead sponsor

Quintiles, Inc.collaborator

Mapped research locations

BarcelonaSpain4 Saint PetersburgRussia4 New YorkNew York, United States2 ChicagoIllinois, United States2 BaltimoreMaryland, United States2 BerlinGermany2 PragueCzechia2 BangkokThailand2 Los AngelesCalifornia, United States1 St LouisMissouri, United States1 MadridSpain1 LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00335153 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.